Clinical Study of Kangfuxin and Basic Fibroblast Growth Factor in Promoting the Healing of Donor Site
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The main objective of this study is to observe whether basic fibroblast growth factor and
Kangfuxin Liquid can promote the wound healing in the donor area and further evaluate the
healing quality.
Phase:
N/A
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators:
Jiangyin Hospital Affiliated to Southeast University School of Medicine Lishui Country People's Hospital Nantong University Taizhou Central Hospital (Taizhou University Hospital) The 59th Central Hospital of the Chinese people's Liberation Army The Second Affiliated Hospital of Kunming Medical University Zhejiang Quhua Hospital